Clicky

LakeShore Biopharma Co., Ltd(LSB)

Description: LakeShore Biopharma Co., Ltd, a biopharmaceutical company, engages in the discovering, developing, manufacturing, commercializing, and sale of vaccines and therapeutic biologics for infectious diseases and cancer. The company's product pipeline includes YSJA, a conventional rabies vaccine which is in marketed stage; PIKA, a rabies vaccine which are in phase I/III and preclinical trials for the treatment of rabies virus; PIKA YS-ON-001, an immuno-oncology therapeutic that is in phase I trials for the treatment of pancreatic and hepatocellular cancer; PIKA YS-HBV-001, a hepatitis B vaccine that is in phase I trials; PIKA YS-HBV-002, an immune-therapy vaccine which is in IND preclinical trials for the treatment of chronic HBV infection; and PIKA YS-ON-001 and PIKA Influenza Vaccine which are in preclinical trials. It operates in China, Singapore, the United States, and the Philippines. The company was formerly known as YS Biopharma Co., Ltd. and changed its name to LakeShore Biopharma Co., Ltd in May 2024. The company was founded in 2002 and is based in Beijing, China.


Keywords: Cancer Biopharmaceutical Infectious Diseases Vaccines Hepatitis B Virology Rabies Chronic Hbv Infection Rabies Virus Conventional Rabies Hbv 001 Hbv 002 On 001 Pancreatic And Hepatocellular Cancer Treatment Of Pancreatic And Hepatocellular Cancer Treatment Of Rabies

Home Page: www.ysbiopharm.com

Building No. 2
Beijing, 102629
China
Phone: 86 10 8920 2086


Officers

Name Title
Dr. Yuan Liu Ph.D. Head of Vaccine Research
Mr. Wang Xu CEO & Director
Dr. Hui Shao C.F.A., M.B.A., Ph.D. President, Chief Business Officer & Vice Chairman
Ms. Rui Yu M.B.A., M.S. CFO & Director
Ms. Zhiyuan Ran Head of Medical & Marketing Department
Dr. Zenaida Reynoso Mojares M.D. Chief Medical Officer

Exchange: NASDAQ

Country: US : United States of America

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0
Price-to-Book MRQ: 1.3909
Price-to-Sales TTM: 0.1993
IPO Date: 2023-03-16
Fiscal Year End: March
Full Time Employees: 758
Back to stocks